Tenon Medical (NASDAQ:TNON) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Tenon Medical (NASDAQ:TNON – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a research note on Thursday, October 15th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold”.

View Our Latest Research Report on Tenon Medical

Tenon Medical Price Performance

Shares of NASDAQ TNON opened at $0.90 on Friday. The company has a market capitalization of $2.41 million, a price-to-earnings ratio of -0.02 and a beta of 1.43. The business has a 50-day moving average of $2.69 and a two-hundred day moving average of $14.83. Tenon Medical has a 1 year low of $0.89 and a 1 year high of $40.95.

Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings data on Thursday, November 12th. The company reported ($5.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.22) by ($1.17). Tenon Medical had a negative return on equity of 3,216.08% and a negative net margin of 305.10%. The business had revenue of $1.43 million for the quarter, compared to analyst estimates of $1.55 million.

Insiders Place Their Bets

In related news, major shareholder Financial Lp Hrt sold 65,582 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $5.56, for a total value of $364,635.92. Following the completion of the sale, the insider directly owned 15,839 shares of the company’s stock, valued at $88,064.84. The trade was a 80.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have acquired 129,945 shares of company stock valued at $500,468 and have sold 136,599 shares valued at $605,467. 17.71% of the stock is currently owned by company insiders.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc. is a medical technology company focused on developing and commercializing implant systems for the treatment of sacroiliac joint disorders, a potential source of lower-back and pelvic pain. The company’s principal product is the Catamaran® Sacroiliac Joint Fusion System, an implant and instrument system designed for sacroiliac joint fusion. Tenon’s products are intended for use by surgeons treating patients with sacroiliac joint dysfunction. Based in the United States, Tenon Medical focuses on the development and commercialization of its surgical technologies in the U.S. market.

Further Reading

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.